Skip to main content
. 2020 Nov 3;15(11):e0241742. doi: 10.1371/journal.pone.0241742

Table 2. Meta-analyses of sociodemographic and clinical potential predictors of in-hospital mortality.

Potential predictor Studies, n Total patients, n Non-survivors, n (% exposed) Survivors, n (% exposed) Pooled odds ratio (95% CI) p-value I2
Symptoms and signs (yes/no)
Dyspnoea 10 7577 1545 (63.5) 6032 (40.4) 2.54 (1.84, 3.50)* <0.001 80.8
Fatigue 9 5884 954 (35.1) 4930 (22.1) 1.30 (0.59, 2.87) 0.52 94.4
Fever 17 10665 2069 (63.3) 8596 (63.5) 0.78 (0.64, 0.95)* 0.013 53.2
Myalgia 9 6608 1114 (19.2) 5494 (22.3) 0.77 (0.36, 1.64) 0.50 92.8
Cough 15 11911 2121 (62.6) 9790 (67.3) 0.74 (0.61, 0.91)* 0.003 63.7
Vomiting 6 5361 879 (7.7) 4482 (10.3) 0.60 (0.40, 0.89)* 0.011 32.0
Diarrhoea 12 9491 1846 (10.0) 7645 (15.8) 0.61 (0.45, 0.82)* 0.001 54.3
Headache 9 7384 1417 (8.6) 5967 (14.2) 0.52 (0.30, 0.90)* 0.020 74.9
Chronic condition (yes/no)
Obesity 17 20289 6885 (14.2) 13404 (17.1) 1.09 (0.84, 1.41) 0.53 82.9
Smoking habit 23 18844 4436 (19.3) 14408 (16.2) 1.55 (1.24, 1.96)* <0.001 73.1
Unspecified comorbidity 13 7644 1412 (77.7) 6232 (43.6) 4.70 (3.19, 6.91)* <0.001 77.3
Stroke 5 1310 228 (14.9) 1082 (4.3) 4.15 (1.80, 9.59)* 0.001 45.5
Kidney disease 30 25413 7746 (14.8) 17667 (6.7) 3.20 (2.52, 4.06)* <0.001 75.8
Cardiovascular disease 32 27052 7642 (30.8) 19410 (14.0) 2.98 (2.51, 3.53)* <0.001 75.9
Hypertension 37 21388 4963 (61.4) 16425 (39.8) 2.61 (2.19, 3.17)* <0.001 79.0
Malignancy 22 12687 2635 (15.8) 10052 (6.9) 2.36 (1.77, 3.15)* <0.001 54.3
Diabetes 38 25498 5673 (33.8) 19825 (20.4) 2.12 (1.79, 2.52)* <0.001 77.9
Pulmonary disease 31 24748 7848 (13.3) 16900 (7.5) 2.00 (1.39, 2.88)* <0.001 88.0
Liver disease 13 13617 4432 (2.5) 9185 (2.7) 1.80 (1.35, 2.39)* <0.001 6.2

* p-value <0.05.